Prelude Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$232K Buy
2021
Q2
$299K Buy
2021
Q1
$324K Buy
2020
Q4
$358K Buy
2020
Q3
$285K Sell
2020
Q2
$368K Buy
2020
Q1
$20K Buy
2019
Q3
Sell
2019
Q2
$7K Buy
2019
Q1
Sell
2018
Q4
$6K Buy